Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 98 insiders$625K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 24 | Alberti-Perez MilenaDirector |  SCHLSCHOLASTIC CORPGrant or award | A | $130K 3,700 sh | Sep 18, 2026 |
| 24 | Kramer Andrea AnigatiChief Operating Officer, 10% Owner |  HLNEHamilton Lane INCGrant or award | A | $1,809 27 sh | Sep 18, 2026 traded Jun 30, 2026 |
| 24 | Budur KumarCHIEF MEDICAL OFFICER |  HRMYHarmony Biosciences Holdings, Inc.Open-market sale | SELL | $77K 1,800 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 24 | Blitzer MichaelDirector |  MRLNMerlin, Inc.Other acquisition or disposition | J | — 262.5K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 24 | Wolff Anne ClarkeDirector | SCHLSCHOLASTIC CORP Grant or award | A | $130K 3,700 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 23 | Sousa Mauad BrunoDirector | AUGOAura Minerals Inc. Derivative conversion | C | $2.64M 30.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 23 | Sandler Alan B.Chief Development Officer |  RVMDRevolution Medicines, Inc.Open-market sale · 10b5-1 plan | SELL | $67K 336 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Feeley KevinCHIEF FINANCIAL OFFICER |  WGSGeneDx Holdings Corp.Open-market sale | SELL | $55K 586 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $14K 148 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Feeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $107K 1,079 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Wetterwald JulienChief Technology Officer | WLTHWEALTHFRONT CORP Open-market sale · 10b5-1 plan | SELL | $264K 26.1K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 22 | Kumar MukulPRESIDENT, ENGINEERING |  PUBMPubMatic, Inc.Open-market sale · 10b5-1 plan | SELL | $134K 8,000 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Feeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $52K 541 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Padisetty SivaprasadChief Technology Officer |  GTLBGitlab Inc.Tax withholding | F | $1.51M 30.9K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Feeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $144K 1,470 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Ross Jessica PChief Financial Officer | GTLBGitlab Inc. Tax withholding | F | $1.59M 32.6K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Mancini AnthonySee Remarks | RVMDRevolution Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $348K 1,747 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Teter Timothy S.EVP, General Counsel and Sec |  NVDANVIDIA CORPTax withholding | F | $7.58M 35.7K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Fortunato DavidDirector, CEO and President | WLTHWEALTHFRONT CORP Open-market sale · 10b5-1 plan | SELL | $507K 50.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 21 | Stetter MarkDirector |  ZTSZoetis Inc.Grant or award | A | $25K 342 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 21 | Lumpkin AlexandraChief Legal Officer |  REAXReal REMAX Group Inc.Option exercise | M | — 302 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 21 | McKee CharlotteCMO and Head of R&D |  SIONSionna Therapeutics, Inc.Grant or award | A | — 50.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 21 | Ridloff ElenaCFO and CBO | SIONSionna Therapeutics, Inc. Grant or award | A | — 47.3K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 21 | McKee CharlotteCMO and Head of R&D | SIONSionna Therapeutics, Inc. Grant or award | A | — 50.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 21 | Epperly Melissa B,Director |  ROIVRoivant Sciences Ltd.Grant or award | A | — 5,054 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 21 | Kodialam Rajini SundarDirector |  STUBStubHub Holdings, Inc.Grant or award | A | — 42.4K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 21 | Blackburn Jeffrey MDirector | STUBStubHub Holdings, Inc. Grant or award | A | — 42.4K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 21 | Patterson ThomasDirector, 10% Owner | STUBStubHub Holdings, Inc. Grant or award | A | — 42.4K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 21 | Budur KumarCHIEF MEDICAL OFFICER | HRMYHarmony Biosciences Holdings, Inc. Open-market sale | SELL | $34K 800 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 21 | Fuchs ThomasDirector | WGSGeneDx Holdings Corp. Option exercise | M | — 1,146 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 21 | Ridloff ElenaCFO and CBO | SIONSionna Therapeutics, Inc. Grant or award | A | — 47.3K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 20 | Guerrier AlixDirector | SCHLSCHOLASTIC CORP Grant or award | A | $130K 3,700 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Dumont Robert LouisDirector | SCHLSCHOLASTIC CORP Grant or award | A | $130K 3,700 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Cislini JeffSVP & General Counsel | RVMDRevolution Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $10K 52 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Anders JackChief Financial Officer | RVMDRevolution Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $12K 61 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Sandler Alan B.Chief Development Officer | RVMDRevolution Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $975 5 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Budur KumarCHIEF MEDICAL OFFICER | HRMYHarmony Biosciences Holdings, Inc. Option exercise | M | $319K 10.4K sh | Sep 18, 2026 traded Sep 18, 2026 |
| 20 | Walker VerdellDirector | SCHLSCHOLASTIC CORP Grant or award | A | $130K 3,700 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Budur KumarCHIEF MEDICAL OFFICER | HRMYHarmony Biosciences Holdings, Inc. Option exercise | M | $770K 25.4K sh | Sep 18, 2026 traded Sep 18, 2026 |
| 20 | Li LindaDirector | SCHLSCHOLASTIC CORP Grant or award | A | $130K 3,700 sh | Sep 18, 2026 traded Sep 16, 2026 |